-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Madrigal Pharmaceuticals, Inc. annual/quarterly Revenues history and growth rate from 2012 to 2024.
- Madrigal Pharmaceuticals, Inc. Revenues for the quarter ending March 31, 2024 was $0.000.
- Madrigal Pharmaceuticals, Inc. Revenues for the twelve months ending March 31, 2024 was $0.000.
- Madrigal Pharmaceuticals, Inc. annual Revenues for 2024 was $180M.
- Madrigal Pharmaceuticals, Inc. annual Revenues for 2023 was $0.000.
- Madrigal Pharmaceuticals, Inc. annual Revenues for 2022 was $0.000.